Erschienen in:
01.04.2011 | Letter
Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months'
verfasst von:
Miguel A Gonzalez-Gay, Carlos Gonzalez-Juanatey, Jose A Miranda-Filloy, Javier Martin, Maria T Garcia-Unzueta, Javier Llorca
Erschienen in:
Arthritis Research & Therapy
|
Ausgabe 2/2011
Einloggen, um Zugang zu erhalten
Excerpt
We read with great interest the study by Engvall and colleagues [
1] in a recent issue of
Arthritis Research & Therapy. The study showed that anti-tumor necrosis factor-alpha (anti-TNF-α) infliximab therapy is associated with an increase of body fat mass in early rheumatoid arthritis (RA) independently of changes in disease activity and levels of leptin and adiponectin. …